News

AIS2018

AIS 2018 : TARGETS FOR MABS INNOVATIVE APPROACHES FOR THEIR DISCOVERY & VALIDATION

Read more

Sans titre

MASTER CLASSES DE L’IMMUNOTHÉRAPIE

Read more

Recruitment, recruit, recruiter.

Development of new immunoconjugates for HER2-positive breast cancers

Read more

bandeau-carré-AIS2017

Assises 2017: Antibody-Drug Conjugates

Read more

Newspaper, The Media, Historic World Event.

Bioterrorisme : un traitement contre l’empoisonnement à la ricine – Le Magazine de la santé

Read more

Recruitment, recruit, recruiter.

2 Years Post-doctoral fellowship in Montpellier

Read more

Newspaper, The Media, Historic World Event.

Allocations doctorales 2016 : Listes des sujets de thèses anticorps

Read more

Recherche

First-in-­human phase I study for SurgiMab’s molecule SGM-­101 launched in Montpellier Cancer Institute.

Read more

Speaker at Business Conference and Presentation. Audience at the conference hall. Business and Entrepreneurship.

MAbDelivery Industrial Workshop

Read more

Recruitment, recruit, recruiter.

PhD Projects 2015

Read more

Recruitment, recruit, recruiter.

Call for proposals 2015: New research team & group leader

Read more

Newspaper, The Media, Historic World Event.

PhD Project 2014 “Design of a method for in silico maturation of antibodies”

Read more

123